Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04730440
Other study ID # 19-02
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2019
Est. completion date March 26, 2020

Study information

Verified date January 2021
Source Centre Hospitalier Princesse Grace
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to evaluate impacts of an emotion recognition rehabilitation program, named Training of Affect Recognition, on social cognition abilities in Alzheimer's disease (AD). In addition, we hypothesis that the effect of this rehabilitation will also evolve gaze strategies, behavioral disorders, and the caregiver's burden.


Description:

It is commonly admitted that social cognition impairment, like deficit in facial emotion recognition or misinterpretation of others' intentions (Theory of Mind), are associated with social behavior disorders. This kind of disorders are observed in Fronto-Temporal Dementia, Alzheimer's Dementia (AD) and Parkinson's Disease, with severe deficits in FTD and lighter deficits in AD and PD. One explanation is that patients apply inappropriate visual exploration strategies to decode emotions and intentions of others. Our study aims to evaluate impacts of an emotion recognition rehabilitation program, named Training of Affect Recognition, on social cognition abilities (facial emotion recognition (FER) and theory of mind (ToM)) in Alzheimer's disease (AD). In addition, we hypothesis that the effect of this rehabilitation will also evolve gaze strategies, behavioral disorders, and the caregiver's burden.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date March 26, 2020
Est. primary completion date March 26, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - AD diagnosed according to l'IWG-2 (Dubois & al. 2014) criteria, - Mini-Mental State (MMS-E) =15 - Subject accompanied by a family caregiver and whose participation in a cognitive stimulation workshop was recommended in Memory Centre of the RAINIER Centre (Princesses Grace Hospital - Monaco) - Written informed consent signed by patient and family caregiver. Exclusion Criteria: - General anaesthesia within 3 months. - Ophthalmological or neurological problems preventing a video-oculography examination. - Oculomotor disorders such as "fixation disorders" or "ocular tracking disorders". - Cognitive disorders of the type: visual agnosia, visuo-spatial disorder, visuo-perceptual disorder or aphasia. - History of bipolar disorder or schizophrenia - History of alcohol abuse.

Study Design


Intervention

Other:
AD-TAR
Intervention description: 12 sessions in groups of 4 subject, over 6 weeks (2 sessions per week), using a rehabilitation program named Training of Affect Recognition (TAR).
AD-Cognitive Stimulation
Intervention description: 12 sessions in groups of 4 subject, over 6 weeks (2 sessions per week), using classic cognitive stimulation workshops.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Centre Hospitalier Princesse Grace Association de Recherche Bibliographique pour les Neurosciences, Universite Cote d'Azur

Outcome

Type Measure Description Time frame Safety issue
Primary Facial emotion recognition (FER) performances Change from Baseline and Comparison of FER performance between AD-TAR group and AD-Cognitive Stimulation group.
Evaluation criteria: Scores to Ekman Faces task (1976) and time to answer. FER was assessed using pictures from the Ekman Faces task (1976), to test the recognition of the six facial basic emotions and neutral faces. There were four pictures per emotion, for a total of 28. For each picture, participants were asked to select one of the seven labels (anger, disgust, fear, sadness, happiness, surprise and neutral), with a maximum of 8 seconds of response time per picture.
Baseline; Week 6; 1 month post intervention
Primary Affective ToM performances Change from Baseline and Comparison of Affective ToM performance between AD-TAR group and AD-Cognitive Stimulation group.
Evaluation criteria: Scores to the " Reading the Mind in the Eyes " test (Baron-Cohen 2001). 36 black-and-white photographs of the eye area of faces. Subjets are asked to choose which word, among four options, best described what the character in the photograph was thinking or feeling. For this task, four scores were obtained: a total score (/36) and three emotional valence sub-scores: positive (/8), neutral (/16) and negative (/12).
Baseline; Week 6; 1 month post intervention
Secondary Eye gaze strategies during Facial emotion recognition (FER) Change from Baseline and Comparison of gaze patterns between AD-TAR group and AD-Cognitive Stimulation group, during Facial emotion recognition tasks.
Evaluation criteria: Eye movements (number and duration of fixations on areas of interest) recorded with an eye-tracking device. FER was assessed using some pictures from the Ekman Faces task (1976).
Baseline; Week 6; 1 month post intervention
Secondary Behavioral disorders Change from Baseline and Comparison between AD-TAR group and AD-Cognitive Stimulation group, Evaluation criteria: Neuropsychiatric Inventory (NPI), a scale that includes ten behavioral items (delusions, hallucinations, agitation, depression, anxiety, euphoria, apathy, disinhibition, irritability and aberrant motor behaviors) and two neurovegetative symptoms (sleep and appetite disorders). The evaluation was based on an interview with patients' primary caregivers. Both the frequency (/5) and the severity (/3) of each behavior were determined and a score was calculated by multiplying the frequency and the severity of each behavior observed during the last month. Baseline; Week 6; 1 month post intervention
Secondary The Family caregiver's burden Change from Baseline and Comparison between AD-TAR group and AD-Cognitive Stimulation group, Evaluation criteria: The burden of the family caregiver was measured with the Zarit scale (completed by the caregiver). Composed of 22 questions on the physical, emotional and financial load felt. Total score /88. Baseline; Week 6; 1 month post intervention
Secondary Global cognitive performance Change from Baseline and Comparison between AD-TAR group and AD-Cognitive Stimulation group, Evaluation criteria: MMSE (MINI MENTAL STATE EXAMINATION). 30-question general cognitive function assessment. The maximum score is 30. Baseline; Week 6; 1 month post intervention
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03255720 - Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes N/A
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A
Withdrawn NCT05497817 - A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia N/A
Completed NCT02317523 - Alzheimer's Caregiver Coping: Mental and Physical Health N/A
Completed NCT03538522 - A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831 Phase 2
Terminated NCT03132272 - Immunoadsorption for Treatment of Alzheimer's Disease N/A
Recruiting NCT03275363 - The University of Hong Kong Neurocognitive Disorder Cohort N/A
Enrolling by invitation NCT03724136 - Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study N/A
Completed NCT02267486 - Exploratory Study for the Validity of QuQu Scale N/A
Active, not recruiting NCT03748303 - Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study Phase 1
Completed NCT03611439 - Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients N/A
Completed NCT04058886 - Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers N/A
Recruiting NCT03584568 - Reappraising Intergeneration Relationships in Dementia Caregiving N/A
Not yet recruiting NCT05113732 - Association of Cognition With Functional Mobility in People With Alzheimer's Disease
Completed NCT03811847 - A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants. Phase 4
Terminated NCT03044249 - A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression Phase 2
Active, not recruiting NCT03661034 - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) N/A
Completed NCT03718494 - Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)
Completed NCT03602391 - The Senior Companion Program Plus N/A
Completed NCT03548584 - A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type Phase 3